LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $11.64 and last traded at $11.4750, with a volume of 503803 shares changing hands. The stock had previously closed at $11.29.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. Zacks Research cut shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday. JPMorgan Chase & Co. lifted their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Thursday, May 14th. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. The Goldman Sachs Group began coverage on LifeStance Health Group in a report on Friday, June 5th. They issued a “neutral” rating and a $9.00 target price on the stock. Finally, BTIG Research lifted their price target on LifeStance Health Group from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $10.75.
Read Our Latest Research Report on LifeStance Health Group
LifeStance Health Group Stock Up 1.7%
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The business had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. The business’s quarterly revenue was up 21.2% compared to the same quarter last year. Sell-side analysts forecast that LifeStance Health Group, Inc. will post 0.12 earnings per share for the current year.
Insider Buying and Selling at LifeStance Health Group
In other news, Director Robert Bessler sold 894,337 shares of LifeStance Health Group stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the transaction, the director owned 539,763 shares in the company, valued at approximately $5,467,799.19. The trade was a 62.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Darren M. Black sold 5,899,661 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $47,315,281.22. Following the completion of the transaction, the director directly owned 23,310,115 shares in the company, valued at $186,947,122.30. The trade was a 20.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 7,762,394 shares of company stock worth $64,107,859 over the last ninety days. Corporate insiders own 3.50% of the company’s stock.
Institutional Investors Weigh In On LifeStance Health Group
A number of hedge funds and other institutional investors have recently bought and sold shares of LFST. Larson Financial Group LLC lifted its holdings in LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after buying an additional 3,791 shares in the last quarter. KBC Group NV acquired a new stake in LifeStance Health Group during the 1st quarter worth $29,000. EverSource Wealth Advisors LLC grew its holdings in LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after acquiring an additional 5,404 shares during the period. Bayesian Capital Management LP bought a new stake in shares of LifeStance Health Group during the 2nd quarter valued at $52,000. Finally, PNC Financial Services Group Inc. lifted its stake in shares of LifeStance Health Group by 615.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after purchasing an additional 7,987 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.
About LifeStance Health Group
LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.
The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.
Featured Stories
- Five stocks we like better than LifeStance Health Group
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
- Sandisk: What the Chart Is Trying to Tell Us
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
